
Keywords: ANGPTL; angiopoietin-like protein; DGF; delayed graft function; ESRD; end stage renal disease; FFA; free fatty acid; LPL; lipoprotein lipase; mTOR; mammalian target of rapamycin; SKP; simultaneous kidney and pancreas; UPC; urine protein to creatinine rati